Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGD | P52209 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9426201 | 0.72 | CTSA (0.31) | — | |
| SCHEMBL4611932 | 0.71 | PGD (0.33) | PGD | |
| SCHEMBL29017996 | 0.69 | CA12 (0.31) | — | |
| SCHEMBL29670664 | 0.68 | PGK1 (0.38) | PGD | |
| SCHEMBL8060226 | 0.66 | FDPS (0.37) | PGD | |
| SCHEMBL9738739 | 0.65 | PGD (0.33) | PGD | |
| SCHEMBL9738277 | 0.65 | PGD (0.33) | PGD | |
| SCHEMBL9738106 | 0.65 | PGD (0.33) | PGD | |
| SCHEMBL9738103 | 0.65 | PGD (0.33) | PGD | |
| SCHEMBL9737448 | 0.65 | PGD (0.33) | PGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0044615-B1 | METHOD FOR THE ANALYSIS OF TRIGLYCERIDES | TECHNICON INSTRUMENTS CORPORATION (a New York corporation) (US) | 1984-05-30 | — | — | EP | claimed |
| US-20260002180-A1 | PLATFORM FOR BIO-BASED PRODUCTION OF HIGH LEVELS OF O-PHOSPHOSERINE, CYSTEATE, OR TAURINE | NATÁUR INC. (US) | 2026-01-01 | — | — | US | disclosed |
| US-20240067997-A1 | GENOMIC ENGINEERING OF BIOSYNTHETIC PATHWAYS LEADING TO INCREASED NADPH | ZYMERGEN INC. | 2024-02-29 | — | — | US | disclosed |
| US-11519012-B2 | Genomic engineering of biosynthetic pathways leading to increased NADPH | ZYMERGEN INC. (US) | 2022-12-06 | — | — | US | disclosed |
| CN-111372451-B | Compositions for hemolysis and coagulation regulation and stabilization of extracellular vesicles | 斯特雷克股份有限公司 | 2022-08-12 | — | — | CN | disclosed |
| US-20200263214-A1 | GENOMIC ENGINEERING OF BIOSYNTHETIC PATHWAYS LEADING TO INCREASED NADPH | ZYMERGEN INC. | 2020-08-20 | — | — | US | disclosed |
| CN-110741091-A | Genome engineering of NADPH-increasing biosynthetic pathways | 齐默尔根公司 | 2020-01-31 | — | — | CN | disclosed |
| CN-105039500-A | Method for determining enzyme activity of plant ribulose-1,2-bisphosphate carboxylase/oxygenase | INST GENETICS & DEV BIOLOG CAS | 2015-11-11 | — | — | CN | disclosed |
| EP-2453006-B1 | METHOD FOR PRODUCING L-LYSINE USING CORYNEBACTERIUM SP. THAT HAS OBTAINED THE ACTIVITY OF GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE DERIVED FROM AN ALIEN SPECIES | CJ CHEILJEDANG CORP (KR) | 2015-10-07 | — | — | EP | disclosed |
| WO-2015002919-A2 | REGULATION OF PRODUCTION PATHWAYS IN HOST CELLS | BUTAMAX ADVANCED BIOFUELS LLC (US) | 2015-01-08 | — | — | WO | disclosed |
| US-20120208245-A1 | METHOD FOR PRODUCING L-LYSINE USING CORYNEBACTERIUM SP. THAT HAS OBTAINED THE ACTIVITY OF GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE DERIVED FROM AN ALIEN SPECIES | CJ CHEILJEDANG CORPORATION (KR) | 2012-08-16 | — | — | US | disclosed |
| EP-2453006-A2 | METHOD FOR PRODUCING L-LYSINE USING CORYNEBACTERIUM SP. THAT HAS OBTAINED THE ACTIVITY OF GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE DERIVED FROM AN ALIEN SPECIES | CJ CheilJedang Corporation (KR) | 2012-05-16 | — | — | EP | disclosed |
| US-20110185456-A1 | Annotatd plant genes | CHEIKH NORDINE | 2011-07-28 | — | — | US | disclosed |
| US-20110183430-A1 | GROUP SPECIFIC INTERNAL STANDARD TECHNOLOGY (GSIST) FOR SIMULTANEOUS IDENTIFICATION AND QUANTIFICATION OF SMALL MOLECULES | PURDUE RESEARCH FOUNDATION (US) | 2011-07-28 | — | — | US | disclosed |
| WO-2009134439-A2 | GROUP SPECIFIC INTERNAL STANDARD TECHNOLOGY (GSIST) FOR SIMULTANEOUS IDENTIFICATION AND QUANTIFICATION OF SMALL MOLECULES | PURDUE RESEARCH FOUNDATION (US) | 2009-11-05 | — | — | WO | disclosed |
| US-20080034453-A1 | Nucleotide sequences coding maize and/or soybean proteinfor use in genome mapping, identification and analysis; plant breeding | MONSANTO TECHNOLOGY LLC | 2008-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260002180-A1 | PLATFORM FOR BIO-BASED PRODUCTION OF HIGH LEVELS OF O-PHOSPHOSERINE, CYSTEATE, OR TAURINE | UROD, DDC, CBS | PGD 14/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.